Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells – a possible role for breast cancer-associated p43-Reference-Cited by-同舟云学术

Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells – a possible role for breast cancer-associated p43

Published:1998-05 Issue:1-2 Volume:127 Page:129-134
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Rosen Harald R,Ausch Christoph,Reinerova Marta,Zaspin Eleonora,Renner Karl,Rosen Alexander C,Schiessel Rudolf,Moroz Chaya

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Generation and decay of the immune response to a progressive fibrosarcoma I. Ly-1+2− suppressor T cells down regulate the generation of Ly-1−2+ effector T cells;North;J. Exp. Med.,1984

2. Generation and decay of the immune response to progressive fibrosarcoma I. Failure to demonstrate postexcision immunity after the onset of T cell mediated suppression of immunity;Bursoker;J. Exp. Med.,1984

3. Lymphocyte bearing surface ferritin in patients with Hodgkin's disease and breast cancer;Moroz;N. Engl. J. Med.,1977

4. T-Cell mitogenesis stimulates the appearance of a new mRNA species coding for a 43kD peptide reactive with CM-H-9 monoclonal antibody specific for placental isoferritin;Moroz;Proc. Natl. Acad. Sci. USA,1989

5. Placental isoferritin: a new serum marker in toxemia of pregnancy;Maymon;Am. J. Obstet. Gynecol.,1989

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The nociceptin/orphanin FQ receptor system as a target to alleviate cancer‐induced bone pain in rats: Model validation and pharmacological evaluation;British Journal of Pharmacology;2020-01-21

2. Inflammatory cytokines in bladder cancer;Journal of Cellular Physiology;2019-02-18

3. Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor;Neoplasia;2017-03

4. New insights of common gamma chain in hematological malignancies;Cytokine;2017-01

5. Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box;Cytokine & Growth Factor Reviews;2016-12